1. Association of thyroid transcription factor‐1 with the efficacy of immune‐checkpoint inhibitors in patients with advanced lung adenocarcinoma. Issue 16 (8th July 2022) Authors: Nakahama, Kenji; Kaneda, Hiroyasu; Osawa, Masahiko; Izumi, Motohiro; Yoshimoto, Naoki; Sugimoto, Akira; Nagamine, Hiroaki; Ogawa, Koichi; Matsumoto, Yoshiya; Sawa, Kenji; Tani, Yoko; Mitsuoka, Shigeki; Watanabe, Tetsuya; Asai, Kazuhisa; Kawaguchi, Tomoya Journal: Thoracic cancer Issue: Volume 13:Issue 16(2022) Page Start: 2309 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. C609T polymorphism of NADPH Quinone Oxidoreductase 1 Correlates Clinical Hematological Toxicities in Lung Cancer Patients Treated with Amrubicin. (January 2013) Authors: Nagata, Misato; Kimura, Tatsuo; Suzumura, Tomohiro; Kira, Yukimi; Nakai, Toshiyuki; Umekawa, Kanako; Tanaka, Hidenori; Matsuura, Kuniomi; Mitsuoka, Shigeki; Yoshimura, Naruo; Oka, Takako; Kudoh, Shinzoh; Hirata, Kazuto Journal: Clinical medicine insights. Oncology Issue: Volume 7(2013) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Case of afatinib‐induced severe purpuric drug eruption with gastrointestinal bleeding. Issue 11 (12th August 2021) Authors: Oku, Aoi; Nakai, Kozo; Ikenaga, Tatsuhiko; Sato, Kanako; Mitsuoka, Shigeki; Takahashi, Shunsuke; Tanoue, Kojiro; Sawada, Akinari; Nagami, Yasuaki; Tsuruta, Daisuke Journal: Journal of dermatology Issue: Volume 48:Issue 11(2021) Page Start: e534 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Dose Escalation Study of Concurrent Chemoradiotherapy With the Use of Involved-field Conformal Radiotherapy and Accelerated Hyperfractionation in Combination With Cisplatin and Vinorelbine Chemotherapy for Stage III Non–small Cell Lung Cancer: The Final Report. (October 2018) Authors: Yoshimura, Naruo; Tada, Takuhito; Matsumoto, Yoshiya; Sawa, Kenji; Yoshimoto, Naoki; Suzumura, Tomohiro; Tanaka, Hidenori; Mitsuoka, Shigeki; Kimura, Tatsuo; Tamiya, Tomohiro; Hirashima, Tomonori; Kawaguchi, Tomoya; Kudoh, Shinzoh; Hosono, Masako; Hirata, Kazuto Journal: American journal of clinical oncology Issue: Volume 41:Number 10(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Epidermal growth factor receptor tyrosine kinase inhibitors in previously treated advanced non-small-cell lung cancer with wild-type EGFR. (22nd January 2016) Authors: Mitsuoka, Shigeki; Kawaguchi, Tomoya; Kubo, Akihito; Isa, Shun-ichi; Asai, Kazuhisa; Uji, Masato; Watanabe, Tetsuya; Sawa, Kenji; Yoshimoto, Naoki; Oka, Takako; Nakai, Toshiyuki; Suzumura, Tomohiro; Tanaka, Hidenori; Matsuura, Kuniomi; Kimura, Tatsuo; Yoshimura, Naruo; Kudoh, Shinzoh; Hirata, Kazuto Journal: Expert opinion on pharmacotherapy Issue: Volume 17:Number 2(2016) Page Start: 193 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Impact of tumor microenvironment on the efficacy of epidermal growth factor receptor‐tyrosine kinase inhibitors in patients with EGFR‐mutant non‐small cell lung cancer. Issue 10 (30th August 2019) Authors: Matsumoto, Yoshiya; Sawa, Kenji; Fukui, Mitsuru; Oyanagi, Jun; Izumi, Motohiro; Ogawa, Koichi; Suzumura, Tomohiro; Watanabe, Tetsuya; Kaneda, Hiroyasu; Mitsuoka, Shigeki; Asai, Kazuhisa; Kimura, Tatsuo; Yamamoto, Nobuyuki; Koh, Yasuhiro; Kawaguchi, Tomoya Journal: Cancer science Issue: Volume 110:Issue 10(2019) Page Start: 3244 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Phase II study of a combination regimen of gefitinib and pemetrexed as first-line treatment in patients with advanced non-small cell lung cancer harboring a sensitive EGFR mutation. Issue 1 (October 2015) Authors: Yoshimura, Naruo; Kudoh, Shinzoh; Mitsuoka, Shigeki; Yoshimoto, Naoki; Oka, Takako; Nakai, Toshiyuki; Suzumira, Tomohiro; Matusura, Kuniomi; Tochino, Yoshihiro; Asai, Kazuhisa; Kimura, Tatsuo; Kawaguchi, Tomoya; Hirata, Kazuto Journal: Lung cancer Issue: Volume 90:Issue 1(2015:Oct.) Page Start: 65 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Phase II study of a combination regimen of gefitinib and pemetrexed as first-line treatment in patients with advanced non-small cell lung cancer harboring a sensitive EGFR mutation. Issue 1 (October 2015) Authors: Yoshimura, Naruo; Kudoh, Shinzoh; Mitsuoka, Shigeki; Yoshimoto, Naoki; Oka, Takako; Nakai, Toshiyuki; Suzumira, Tomohiro; Matusura, Kuniomi; Tochino, Yoshihiro; Asai, Kazuhisa; Kimura, Tatsuo; Kawaguchi, Tomoya; Hirata, Kazuto Journal: Lung cancer Issue: Volume 90:Issue 1(2015:Oct.) Page Start: 65 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Phase II Study of the Modified Weekly Nab-paclitaxel Regimen in Previously Treated Patients With Advanced Non–Small Cell Lung Cancer. (10th December 2021) Authors: Yoshimura, Naruo; Sawa, Kenji; Nakai, Toshiyuki; Matsumoto, Yoshiya; Mitsuoka, Shigeki; Kimura, Tatsuo; Asai, Kazuhisa; Yana, Takashi; Kawaguchi, Tomoya; Hirata, Kazuto Journal: American journal of clinical oncology Issue: Volume 44:Number 12(2021) Page Start: 613 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Phase II Study of the Modified Weekly Nab-paclitaxel Regimen in Previously Treated Patients With Advanced Non–Small Cell Lung Cancer. (December 2021) Authors: Yoshimura, Naruo; Sawa, Kenji; Nakai, Toshiyuki; Matsumoto, Yoshiya; Mitsuoka, Shigeki; Kimura, Tatsuo; Asai, Kazuhisa; Yana, Takashi; Kawaguchi, Tomoya; Hirata, Kazuto Journal: American journal of clinical oncology Issue: Volume 44:Number 12(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗